Insider Profile
Slepcev, Gordana
1
Companies Filed At
1
Open-Market Buys (2yr)
$1K
Buy Value (2yr, open-market)
Apr 29, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Apr 29, 2026 $LMR
Lomiko Metals Inc.
Open Market Sell 325,000 $0.15 $49K 64
Apr 29, 2026 $LMR
Lomiko Metals Inc.
Open Market Sell 650,000 $0.10 $65K 64
Apr 02, 2026 $LMR
Lomiko Metals Inc.
Other Buy 300,000 $0.10 $30K 64
Sep 15, 2025 $LMR
Lomiko Metals Inc.
Comp. Grant Buy 100,000 64
Aug 21, 2025 $LMR
Lomiko Metals Inc.
Exercise Buy 88,889 64
Aug 21, 2025 $LMR
Lomiko Metals Inc.
Exercise Sell 88,889 64
Aug 07, 2025 $LMR
Lomiko Metals Inc.
Open Market Buy 10,000 $0.12 $1K 64
Jun 02, 2025 $LMR
Lomiko Metals Inc.
Exercise Buy 200,000 $0.11 $22K 64
Jun 02, 2025 $LMR
Lomiko Metals Inc.
Exercise Sell 200,000 $0.11 $22K 64
Aug 14, 2024 $LMR
Lomiko Metals Inc.
Comp. Grant Buy 88,889 64
Sep 14, 2023 $LMR
Lomiko Metals Inc.
Exercise Sell 83,333 64
Sep 14, 2023 $LMR
Lomiko Metals Inc.
Exercise Buy 83,333 64
Sep 14, 2023 $LMR
Lomiko Metals Inc.
Buyback Buy 50,000 64
May 18, 2023 $LMR
Lomiko Metals Inc.
Open Market Buy 110,000 $0.03 $3K 64
Feb 24, 2023 $LMR
Lomiko Metals Inc.
Comp. Grant Buy 3,200,000 $0.05 $160K 64
Feb 07, 2023 $LMR
Lomiko Metals Inc.
Other Buy 250,000 64
Oct 06, 2022 $LMR
Lomiko Metals Inc.
Open Market Buy 333,334 $0.03 $10K 64
Feb 07, 2022 $LMR
Lomiko Metals Inc.
Comp. Grant Buy 416,667 $0.07 $29K 64
Feb 07, 2022 $LMR
Lomiko Metals Inc.
Comp. Grant Buy 250,000 64
Feb 07, 2022 $LMR
Lomiko Metals Inc.
Comp. Grant Buy 833,333 64
Jan 19, 2022 $LMR
Lomiko Metals Inc.
Open Market Sell 500,000 $0.08 $40K 64
Jan 19, 2022 $LMR
Lomiko Metals Inc.
Open Market Sell 500,000 $0.11 $55K 64
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.